Evelyne M. Loyer, M.D.
Department of Abdominal Imaging, Division of Diagnostic Imaging - Clinical
About Dr. Evelyne M. Loyer
Dr. Evelyne Loyer is a Clinical Professor of Radiology and a board-certified radiologist in the Department of Abdominal Imaging at MD Anderson Cancer Center. Dr. Loyer has served as a radiologist with MD Anderson Cancer Center since 1990.
Dr. Loyer's clinical research focuses on the imaging of hepatobiliary malignancies particularly, preoperative staging and assessment of the response to chemotherapy. Dr. Loyer developed non size based criteria of response to bevacizumab, which correlate with the pathologic response in patients with metastatic colorectal carcinoma. Radiographic observations have also lead to the development of the new pathologic indicator of response in the same patient's population.
Present Title & Affiliation
Primary Appointment
Adjunct Faculty, Division of Diagnostic Imaging - Clinical, The University of Texas Graduate School of Biomedical Science, Houston, TX
Clinical Professor, Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Adjunct Faculty, The University of Texas Graduate School of Biomedical Science, Houston, TX
Clinical Professor, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Colorectal Liver Metastases
Clinical Interests
CT
PET/CT
Hepato-biliary Cancer
Education & Training
Degree-Granting Education
| 1984 | Medical School Paris V, Paris, FR, Medicine, Thesis |
| 1978 | Medical School Paris V, Paris, FR, MD |
| 1971 | Lycee D'Etat Mixte De Chantilly, Paris, FR, General Studies, BS |
Postgraduate Training
| 1987-1990 | Clinical Fellowship, Cross Sectional Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 1985-1987 | Clinical Fellowship, Pediatric Radiology, Children's Hospital National Medical Center, Washington, DC |
| 1981-1985 | Clinical Residency, Radiology, Universite Paris Descartes Medical School Paris V, Paris |
| 1980-1981 | Clinical Internship, Diagnostic Radiology, Nominated Internat Des Hospitaux Prives de Paris, Paris |
| 1979-1980 | Clinical Internship, Surgery, Centre Medico Chirurgical de la Porte de Choisy, Paris |
| 1978-1979 | Clinical Internship, Internal Medicine, Centre Hospitalier Mantes La Jolie, Paris |
Board Certifications
| 1992 | American Board of Radiology |
| 1988 | Certified to Practice Diagnostic Radiology in France |
| 1988 | FLEX |
| 1986 | Educational Commission for Foreign Medical Graduates |
Experience & Service
Academic Appointments
Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2019
Associate Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1999 - 2006
Assistant Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1990 - 1999
Administrative Appointments/Responsibilities
Abdominal Imaging Section Scheduler, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TN, 2009 - 2011
Physician Liaison for Nursing, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1997 - 2000
Other Appointments/Responsibilities
Member, Expert Group on OncoSurgery Management of Liver Metastases (EGOSLIM), Houston, TX, 2010 - Present
Institutional Committee Activities
Member, Diagnostic Imaging Promotion and Tenure Committee, 2013 - Present
Member, Body Imaging Peer Review Committee, 2005 - Present
Member, Alternate, Pharmacy Committee, 1995 - 1997
Member, Utilization Committee, 1992 - 1993
Honors & Awards
| 2022 | Certificate of Merit "Revisiting response assessment of colorectal liver metastases: lessons learned and opportunities for improvement", European Society of Gastrointestinal and Abdominal Radiology |
| 2018 | Department of Diagnostic Radiology Clinical Award |
| 2017 | Diagnostic Imaging Research Award |
| 2016 | Provost's Distinguished Faculty Mentors Nominee |
| 2014 | Best Doctors in America, Best Doctors in America, Inc |
| 2013 | Certificate of Merit "Pre-operative imaging of hilar cholangiocarcinoma: what the surgeon wants to know", Radiological Society of North America |
| 2013 | Certificate of Merit "Atypical imaging presentations of focal nodular hyperplasia with radiologic pathologic correlation", Radiological Society of North America |
| 2012 | Certificate of Merit "Strengths and limitations of extravascular and live specific contrast agents in the evaluation of liver lesions", Radiological Society of North America |
| 2009 | Certificate of Merit "New CT findings of response and recurrence independent of change in tumor size in colorectal liver metastasis treated with Bevacizumab", Radiological Society of North America |
| 2004 | Certificate of Merit "Gastrointestinal stromal tumor (GIST): role of CT in diagnosis, response evaluation, and surveillance after treatment with Imatinib", Radiological Society of North America |
| 2000 | Cum Laude "Radiofrequency (RF) ablation of liver tumors: assessment of therapeutic response and complications", Radiological Society of North America |
| 1996 | Certificate of Merit, Radiological Society of North America |
| 1994 | Certificate of Merit "Diagnosis and staging of pancreatic adenocarcinoma: state-of-the-art CT", Radiological Society of North America |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Mazard T, Mollevi C, Loyer EM, Léger J, Chautard R, Bouché O, Borg C, Armand-Dujardin P, Bleuzen A, Assenat E, Lecomte T. Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial. Cancer Imaging 24(1):77, 2024. e-Pub 2024. PMID: 38886836.
- Popnoe DO, Ng CS, Zhou S, Kaur H, Kang HC, Loyer EM, Kappadath SC, Jones AK. Comparison of virtual to true unenhanced abdominal computed tomography images acquired using rapid kV-switching dual energy imaging. PLoS One 15(9):e0238582, 2020. e-Pub 2020. PMID: 32966278.
- Yedururi S, Kang H, Cox VL, Chawla S, Le O, Loyer EM, Marcal L. Tumor thrombus in the venous drainage pathways of primary, recurrent and metastatic disease on routine oncologic imaging studies: beyond primary tumor in hepatocellular carcinoma and renal cell carcinoma. Br J Radiol 92(1098):20180478, 2019. e-Pub 2019. PMID: 30844299.
- Marcal LP, Patnana M, Yedururi S, Chuang HH, Devine CE, Cox V, Dasari A, Loyer E. Abdominal manifestations of neuroendocrine tumors. Digestive Disease Interventions. e-Pub 2019.
- Lee AJ, Loyer EM, Kang HC, Aloia TA, Tzeng CD, Vauthey JN, Chun YS. Intrahepatic recurrence patterns predict survival after resection of colorectal liver metastases. Ann Surg Oncol 26(1):275-281, 2019. e-Pub 2019. PMID: 30362064.
- Overman MJ, Ferrarotto R, Raghav K, George B, Qiao W, Machado KK, Saltz LB, Mazard T, Vauthey JN, Hoff PM, Hobbs B, Loyer EM, Kopetz S. The addition of Bevacizumab to Oxaliplatin-based chemotherapy: impact upon hepatic sinusoidal injury and thrombocytopenia. J Natl Cancer Inst 110(8):888-894, 2018. e-Pub 2018. PMID: 29346573.
- Mazard T, Boonsirikamchai P, Overman MJ, Asran MA, Choi H, Herron D, Eng C, Maru DM, Ychou M, Vauthey JN, Loyer EM, Kopetz S. Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with Bevacizumab. Gut 67(6):1095-1102, 2018. e-Pub 2018. PMID: 29084828.
- Yedururi S, Terpenning S, Gupta S, Fox P, Martin SS, Conrad C, Loyer EM. Radiofrequency ablation of hepatic tumor: subjective assessment of the perilesional vascular network on contrast-enhanced computed tomography before and after ablation can reliably predict the risk of local recurrence. J Comput Assist Tomogr 41(4):607-613, 2017. e-Pub 2017. PMID: 28722702.
- Yamashita S, Loyer E, Kang HC, Aloia TA, Chun YS, Mehran RJ, Eng C, Lee JE, Vauthey JN, Conrad C. Total transthoracic approach facilitates laparoscopic hepatic resection in patients with significant prior abdominal surgery. Ann Surg Oncol 24(5):1376-1377, 2017. e-Pub 2017. PMID: 27878479.
- Bache ST, Stauduhar PJ, Liu X, Loyer EM, John RX. Quantitation of clinical feedback on image quality differences between two CT scanner models. J Appl Clin Med Phys 18(2):163-169, 2017. e-Pub 2017. PMID: 28300384.
- Yamashita S, Loyer EM, Chun YS, Javle M, Lee JE, Vauthey JN, Conrad C. Laparoscopic management of gallbladder cancer: a stepwise approach. Ann Surg Oncol 23(Suppl 5):892-893, 2016. e-Pub 2016. PMID: 27456958.
- Frentzas S, Simoneau E, Bridgeman VL, Vermeulen PB, Foo S, Kostaras E, Nathan MR, Wotherspoon A, Gao ZH, Shi Y, Van den Eynden G, Daley F, Peckitt C, Tan X, Salman A, Lazaris A, Gazinska P, Berg TJ, Eltahir Z, Ritsma L, van Rheenen J, Khashper A, Brown G, Nyström H, Sund M, Van Laere S, Loyer EM, Dirix L, Cunningham D, Metrakos P, Reynolds AR. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med 22(11):1294-1302, 2016. e-Pub 2016. PMID: 27748747.
- Ismael HN, Loyer EM, Kaur H, Conrad C, Vauthey JN, Aloia T. Evaluating the clinical applicability of the European staging system for perihilar cholangiocarcinoma. J Gastrointest Surg 20(4):741-747, 2016. e-Pub 2016. PMID: 26801328.
- Peungjesada S, Aloia TA, Fox P, Chasen B, Shin S, Baiomy A, Loyer EM. (18)F-FDG uptake at the surgical margin after hepatic resection: patterns of uptake and differential diagnosis. Eur Radiol 25(8):2453-2459, 2015. e-Pub 2015. PMID: 25678079.
- Mise Y, Zimmitti G, Shindoh J, Kopetz S, Loyer EM, Andreou A, Cooper AB, Kaur H, Aloia TA, Maru DM, Vauthey JN. RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases. Ann Surg Oncol 22(3):834-842, 2015. e-Pub 2015. PMID: 25227306.
- Westin JR, McLaughlin P, Romaguera J, Hagemeister FB, Pro B, Dang NH, Samaniego F, Rodriguez MA, Fayad L, Oki Y, Fanale M, Fowler N, Nastoupil L, Feng L, Loyer EM, Younes A. Paclitaxel, Topotecan and Rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Br J Haematol 167(2):177-184, 2014. e-Pub 2014. PMID: 25039868.
- Zhou JH, Rosen D, Andreou A, Brouquet A, Abbott D, Loyer EM, Gonzalez-Angulo AM, Kopetz S, Meric-Bernstam F, Kuerer H, Abdalla E, Vauthey JN, Sahin AA, Maru DM. Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer. Ann Diagn Pathol 18(5):266-270, 2014. e-Pub 2014. PMID: 25205085.
- Huang SY, Aloia TA, Shindoh J, Ensor J, Shaw CM, Loyer EM, Vauthey JN, Wallace MJ. Efficacy and safety of portal vein embolization for two-stage hepatectomy in patients with colorectal liver metastasis. J Vasc Interv Radiol 25(4):608-617, 2014. e-Pub 2014. PMID: 24315549.
- Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog 52 Suppl 1:139-147, 2013. e-Pub 2013. PMID: 23776098.
- Peungjesada S, Aloia TA, Kaur H, Marcal L, Choi H, Vauthey JN, Loyer EM. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol 201(4):W582-W589, 2013. e-Pub 2013. PMID: 24059396.
- Shindoh J, Chun YS, Loyer EM, Vauthey JN. Non-size-based response criteria to preoperative chemotherapy in patients with colorectal liver metastases: the morphologic response criteria. Curr Colorectal Cancer Rep 9(2):198-202, 2013. e-Pub 2013. PMID: 23710157.
- Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg 257(6):1079-1088, 2013. e-Pub 2013. PMID: 23426338.
- Chun YS, House MG, Kaur H, Loyer EM, Paradis V, Vauthey JN. SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions. J Gastrointest Surg 17(4):636-644, 2013. e-Pub 2013. PMID: 23377783.
- Peungjesada S, Chuang HH, Prasad SR, Choi H, Loyer EM, Bronstein Y. Evaluation of cancer treatment in the abdomen: trends and advances. World J Radiol 5(3):126-142, 2013. e-Pub 2013. PMID: 23671749.
- Adams RB, Aloia TA, Loyer EM, Pawlik TM, Taouli B, Vauthey JN. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) 15(2):91-103, 2013. e-Pub 2013. PMID: 23297719.
- Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, Curley SA, Charnsangavej C, Aloia TA, Vauthey JN. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol 30(36):4566-4572, 2012. e-Pub 2012. PMID: 23150701.
- Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer EM, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Tabernero J, Teh C, Van Cutsem E, EGOSLIM group JVOT. The OncoSurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 17(10):1225-1239, 2012. e-Pub 2012. PMID: 22962059.
- Asran MK, Loyer EM, Kaur H, Choi H. Case 177: congenital absence of the portal vein with hepatic adenomatosis. Radiology 262(1):364-367, 2012. e-Pub 2012. PMID: 22190661.
- Brouquet A, Overman MJ, Kopetz S, Maru DM, Loyer EM, Andreou A, Cooper A, Curley SA, Garrett CR, Abdalla EK, Vauthey JN. Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?. Cancer 117(19):4484-4492, 2011. e-Pub 2011. PMID: 21446046.
- Eckmann KR, Patel DK, Landgraf A, Slade JH, Lin E, Kaur H, Loyer E, Weatherly JM, Javle M. Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis. Gastrointest Cancer Res 4(5-6):155-160, 2011. e-Pub 2011. PMID: 22295126.
- Brouquet A, Vauthey JN, Badgwell BD, Loyer EM, Kaur H, Curley SA, Abdalla EK. Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg 98(7):1003-1009, 2011. e-Pub 2011. PMID: 21541936.
- Boonsirikamchai P, Loyer EM, Choi H, Charnsangavej C. Planning and follow-up after ablation of hepatic tumors: imaging evaluation. Surg Oncol Clin N Am 20(2):301-315, 2011. e-Pub 2011. PMID: 21377585.
- Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey JN. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 29(8):1083-1090, 2011. e-Pub 2011. PMID: 21263087.
- Mohamed AA, Kaur H, Loyer EM, Choi H. Diagnosis please: part 1. Radiology 260(3):908-910, 2011. e-Pub 2011.
- Maru DM, Kopetz S, Boonsirikamchai P, Agarwal A, Chun YS, Wang H, Abdalla EK, Kaur H, Charnsangavej C, Vauthey JN, Loyer EM. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol 34(9):1287-1294, 2010. e-Pub 2010. PMID: 20697255.
- Overman MJ, Maru DM, Charnsangavej C, Loyer EM, Wang H, Pathak P, Eng C, Hoff PM, Vauthey JN, Wolff RA, Kopetz S. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol 28(15):2549-2555, 2010. e-Pub 2010. PMID: 20406923.
- Chun YS, Vauthey JN, Boonsirikamchai P, Maru DM, Kopetz S, Palavecino M, Curley SA, Abdalla EK, Kaur H, Charnsangavej C, Loyer EM. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with Bevacizumab for colorectal liver metastases. JAMA 302(21):2338-2344, 2009. e-Pub 2009. PMID: 19952320.
- Wang M, Oki Y, Pro B, Romaguera JE, Rodriguez MA, Samaniego F, McLaughlin P, Hagemeister F, Neelapu S, Copeland A, Samuels BI, Loyer EM, Ji Y, Younes A. Phase II study of yttrium-90-Ibritumomab Tiuxetan in patients with relapsed or refractory mantle cell lymphoma. J Clin Oncol 27(31):5213-5218, 2009. e-Pub 2009. PMID: 19770379.
- Lee SJ, Gounder M, Rubin EH, Li JM, Gu Z, Thalasila A, Loyer EM, Kudelka AP, Verschraegen CF. Optimal modeling for phase I design of a two drug combination-results of a phase I study of Cisplatin with 9-nitrocamptothecin. Invest New Drugs 26(6):541-551, 2008. e-Pub 2008. PMID: 18600301.
- Kaur H, Loyer EM, David CL, Sawaf H, DuBrow RA, Ibrahim NK. Radiologic findings in taxane induced colitis. Eur J Radiol 66(1):75-78, 2008. e-Pub 2008. PMID: 17553645.
- Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94(11):1386-1394, 2007. e-Pub 2007. PMID: 17583900.
- Tamm EP, Loyer EM, Faria SC, Evans DB, Wolff RA, Charnsangavej C. Retrospective analysis of dual-phase MDCT and follow-up EUS/EUS-FNA in the diagnosis of pancreatic cancer. Abdom Imaging 32(5):660-667, 2007. e-Pub 2007. PMID: 17712589.
- Tamm EP, Loyer EM, Faria S, Raut CP, Evans DB, Wolff RA, Crane CH, Dubrow RA, Charnsangavej C. Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging 31(5):568-574, 2006. e-Pub 2006. PMID: 16967235.
- Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, Curley SA, Zorzi D, Abdalla EK. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141(5):460-466, discussion 466-467, 2006. e-Pub 2006. PMID: 16702517.
- Pro B, Fayad L, McLaughlin P, Romaguera J, Hagemeister FB, Rodriguez MA, Goy A, Loyer E, Younes A. Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after Paclitaxel and Topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 47(3):481-485, 2006. e-Pub 2006. PMID: 16396772.
- Hong X, Choi H, Loyer EM, Benjamin RS, Trent JC, Charnsangavej C. Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with Imatinib. Radiographics 26(2):481-495, 2006. e-Pub 2006. PMID: 16549611.
- Oki Y, McLaughlin P, Pro B, Hagemeister FB, Bleyer A, Loyer E, Younes A. Phase II study of Oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma. Cancer 104(4):781-787, 2005. e-Pub 2005. PMID: 15973667.
- Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241(5):715-722, discussion 722-724, 2005. e-Pub 2005. PMID: 15849507.
- Mullen JT, Walsh GL, Abdalla EK, Loyer EM, Curley SA, Vauthey JN. Transdiaphragmatic radiofrequency ablation of liver tumors. J Am Coll Surg 199(5):826-829, 2004. e-Pub 2004. PMID: 15501127.
- Younes A, Pro B, Robertson MJ, Flinn IW, Romaguera JE, Hagemeister F, Dang NH, Fiumara P, Loyer EM, Cabanillas FF, McLaughlin PW, Rodriguez MA, Samaniego F. Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease. Clin Cancer Res 10(16):5432-5438, 2004. e-Pub 2004. PMID: 15328181.
- Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, Loyer E, Vallone P, Fiore F, Scordino F, De Rosa V, Orlando R, Pignata S, Daniele B, Izzo F. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239(4):450-458, 2004. e-Pub 2004. PMID: 15024305.
- Verschraegen CF, Gilbert BE, Loyer E, Huaringa A, Walsh G, Newman RA, Knight V. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(S)-Camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res 10(7):2319-2326, 2004. e-Pub 2004. PMID: 15073107.
- Faria SC, Tamm EP, DuBrow R, David C, Loyer EM, Herron D, Sawaf Y, Ball G, Silverman PM, Charnsangavej C. Use of thin-section, multidetector row helical CT images for coronal oblique reformations for optimal visualization of structures in the hepatoduodenal ligament. Abdom Imaging 29(2):231-238, 2004. e-Pub 2004. PMID: 15290952.
- Bronstein YL, Loyer EM, Kaur H, Choi H, David C, DuBrow RA, Broemeling LD, Cleary KR, Charnsangavej C. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 182(3):619-623, 2004. e-Pub 2004. PMID: 14975959.
- Yovichevich S, Loyer E, J-N V. Diagnosis please comments [letter]: Drs Loyer and Vauthey respond. Radiology 230(2):595, 2004. e-Pub 2004.
- Verschraegen CF, Kudelka AP, Hu W, Vincent M, Kavanagh JJ, Loyer E, Bastien L, Duggal A, De Jager R. A phase II study of intravenous Exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan. Cancer Chemother Pharmacol 53(1):1-7, 2004. e-Pub 2004. PMID: 14586557.
- Verschraegen CF, Westphalen S, Hu W, Loyer E, Kudelka A, Völker P, Kavanagh J, Steger M, Schulz KD, Emons G. Phase II study of Cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer. Gynecol Oncol 90(3):552-559, 2003. e-Pub 2003. PMID: 13678723.
- Vauthey JN, Loyer EM, Chokshi P, Lahoti S. Case 57. Radiology 225(3):744-745, 2002. e-Pub 2002.
- Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, Lerut J, Materne R, Wang X, Encarnacion A, Herron D, Mathey C, Ferrari G, Charnsangavej C, Do KA, Denys A. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 8(3):233-240, 2002. e-Pub 2002. PMID: 11910568.
- Verschraegen CF, Kavanagh JJ, Loyer E, Bodurka-Bevers D, Kudelka AP, Hu W, Vincent M, Nelson T, Levenback C. Phase II study of Carboplatin and liposomal Doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer 92(9):2327-2333, 2001. e-Pub 2001. PMID: 11745287.
- Choi H, Loyer EM, DuBrow RA, Kaur H, David CL, Huang S, Curley S, Charnsangavej C. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21 Spec No:S41-S54, 2001. e-Pub 2001. PMID: 11598247.
- Verschraegen CF, Levenback C, Vincent M, Wolf J, Bevers M, Loyer E, Kudelka AP, Kavanagh JJ. Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan. Ann N Y Acad Sci 922:349-351, 2000. e-Pub 2000. PMID: 11193920.
- Verschraegen CF, Vincent M, Abbruzzese JL, Siegler D, Kavanagh JJ, Loyer E, Kudelka AP, Rubin E. Phase I study of 9-nitro-20(S)-Camptothecin in combination with Cisplatin for patients with advanced malignancies. Ann N Y Acad Sci 922:345-348, 2000. e-Pub 2000. PMID: 11193919.
- Loyer EM, Chin H, DuBrow RA, David CL, Eftekhari F, Charnsangavej C. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT-a comparative study. Radiology 212(3):866-875, 1999. e-Pub 1999. PMID: 10478259.
- Ng CS, Loyer EM, Iyer RB, David CL, DuBrow RA, Charnsangavej C. Metastases to the pancreas from renal cell carcinoma: findings on three-phase contrast-enhanced helical CT. AJR Am J Roentgenol 172(6):1555-1559, 1999. e-Pub 1999. PMID: 10350288.
- Verschraegen CF, Gupta E, Loyer E, Kavanagh JJ, Kudelka AP, Freedman RS, Edwards CL, Harris N, Steger M, Steltz V, Giovanella BC, Stehlin JS. A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer. Anticancer Drugs 10(4):375-383, 1999. e-Pub 1999. PMID: 10378672.
- Verschraegen CF, Matei C, Loyer E, Malpica A, Tornos C, Kudelka AP, Kavanagh JJ. Octreotide induced remission of a refractory small cell carcinoma of the endometrium. Int J Gynecol Cancer 9(1):80-85, 1999. e-Pub 1999. PMID: 11240747.
- Verschraegen CF, Kudelka AP, Loyer EM, Edwards CL, Freedman RS, Kavanagh JJ. A phase II trial of high-dose Hydroxyurea administered parenterally in patients with epithelial ovarian carcinoma refractory to platinum. Int J Gynecol Cancer 8(6):494-498, 1998. e-Pub 1998.
- Corral DA, Amling M, Priemel M, Loyer EM, Fuchs S, Ducy P, Baron R, Karsenty G. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc Natl Acad Sci U S A 95(23):13835-13840, 1998. e-Pub 1998. PMID: 9811887.
- Kaur H, Loyer EM, Minami M, Charnsangavej C. Patterns of uterine enhancement with helical CT. Eur J Radiol 28(3):250-255, 1998. e-Pub 1998. PMID: 9881261.
- Loyer EM, David C, Sella A, Ellerhorst J. Hyperplasia of axillary nodes in patients undergoing immunotherapy. AJR Am J Roentgenol 169(5):1359-1362, 1997. e-Pub 1997. PMID: 9353459.
- Kudelka AP, Levy T, Verschraegen CF, Edwards CL, Piamsomboon S, Termrungruanglert W, Freedman RS, Kaplan AL, Kieback DG, Meyers CA, Jaeckle KA, Loyer E, Steger M, Mante R, Mavligit G, Killian A, Tang RA, Gutterman JU, Kavanagh JJ. A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. Clin Cancer Res 3(9):1501-1505, 1997. e-Pub 1997. PMID: 9815836.
- Kudelka AP, Winn R, Edwards CL, Downey G, Greenberg H, Dakhil SR, Freedman RS, LoCoco S, Umbreit J, Delmore JE, Arbuck S, Loyer E, Gacrama P, Fueger R, Kavanagh JJ. An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Anticancer Drugs 8(7):657-661, 1997. e-Pub 1997. PMID: 9311440.
- Luo G, Ducy P, McKee MD, Pinero GJ, Loyer EM, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386(6620):78-81, 1997. e-Pub 1997. PMID: 9052783.
- Kudelka AP, Winn R, Edwards CL, Downey G, Greenberg H, Dakhil SR, Freedman RS, Loyer E, Rusinkiewicz J, Gacrama P, Fueger R, Kavanagh JJ. Activity of Paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Clin Cancer Res 2(8):1285-1288, 1996. e-Pub 1996. PMID: 9816298.
- Loyer EM, David CL, Dubrow RA, Evans DB, Charnsangavej C. Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. Abdom Imaging 21(3):202-206, 1996. e-Pub 1996. PMID: 8661548.
- Loyer EM, DuBrow RA, David CL, Coan JD, Eftekhari F. Imaging of superficial soft-tissue infections: sonographic findings in cases of cellulitis and abscess. AJR Am J Roentgenol 166(1):149-152, 1996. e-Pub 1996. PMID: 8571865.
- Loyer EM, Sahin A, David CL. Granular cell tumor of the breast: sonographic and histologic patterns. Breast Dis 9(2):101-106, 1996. e-Pub 1996.
- Evans GR, David CL, Loyer EM, Strom E, Waldron C, Ortega R, Ainslie N, Wang B, Janjan N. The long-term effects of internal mammary chain irradiation and its role in the vascular supply of the pedicled transverse rectus abdominis musculocutaneous flap breast reconstruction. Ann Plast Surg 35(4):342-348, 1995. e-Pub 1995. PMID: 8585674.
- Loyer EM, Kroll SS, David CL, DuBrow RA, Libshitz HI. Mammographic and CT findings after breast reconstruction with a rectus abdominis musculocutaneous flap. AJR Am J Roentgenol 156(6):1159-1162, 1991. e-Pub 1991. PMID: 1827564.
- Cauquil P, Pariente D, Loyer EM, Lallemand D. Aspect echographique singulier d'une distomatose hepatique. J Radiol 67(10):715-717, 1986. e-Pub 1986.
Invited Articles
- Choi H, Loyer EM, Charnsangavej C. Neoplasms of the liver and the bile ducts. Semin Roentgenol 39(3):412-427, 2004. e-Pub 2004. PMID: 15372754.
- Faria SC, Tamm EP, Loyer EM, Szklaruk J, Choi H, Charnsangavej C. Diagnosis and staging of pancreatic tumors. Semin Roentgenol 39(3):397-411, 2004. e-Pub 2004. PMID: 15372753.
- Charnsangavej C, Loyer EM, Iyer RB, Choi H, Kaur H. Tumors of the liver, bile duct and pancreas. Curr Probl Diagn Radiol 29(3):69-108, 2000. e-Pub 2000. PMID: 10875047.
- Loyer EM, Whitman GJ, Fenstermacher MJ. Imaging of ovarian carcinoma. Int J Gynecol Cancer 9(5):351-361, 1999. e-Pub 1999. PMID: 11240793.
- Loyer EM, Delpassand ES. Radiation-induced heart disease: imaging features. Semin Roentgenol 28(4):321-323, 1993. e-Pub 1993. PMID: 8272880.
Other Articles
- Ren L, Zhu D, Benson AB, Nordlinger B, Koehne CH, Delaney CP, Kerr D, Lenz HJ, Fan J, Wang J, Gu J, Li J, Shen L, Tsarkov P, Tejpar S, Zheng S, Zhang S, Gruenberger T, Qin X, Wang X, Zhang Z, Poston GJ, Xu J, Group S Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019). Eur J Surg Oncol 46(6):955-966, 2020. PMID: 32147426.
- Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer EM, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Teh C, Tejpar S, Van Cutsem E, Vauthey JN, Påhlman L, EGOSLIM group OT Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 41(9):729-741, 2015. PMID: 26417845.
- Boonsirikamchai P, Asran MA, Maru DM, Vauthey JN, Kaur H, Kopetz S, Loyer EM CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with Bevacizumab. AJR Am J Roentgenol 197(6):W1060-W1066, 2011. PMID: 22109320.
- Donadon M, Vauthey JN, Loyer EM, Charnsangavej C, Abdalla EK Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-Bevacizumab for colorectal liver metastases. World J Gastroenterol 12(40):6556-6558, 2006. PMID: 17072991.
- Vauthey JN, Loyer E, Chokshi P, Lahoti S Case 57: eosinophilic cholangiopathy. Radiology 227(1):107-112, 2003. PMID: 12668742.
- Koenig TR, Loyer EM, Whitman GJ, Raymond AK, Charnsangavej C Cystic lymphangioma of the pancreas. AJR Am J Roentgenol 177(5):1090, 2001. PMID: 11641176.
- Loyer EM, Fuller L, Libshitz HI, Palmer JL Radiographic appearance of the chest following therapy for Hodgkin disease. Eur J Radiol 35(2):136-148, 2000. PMID: 10963919.
- Kudelka AP, Verschraegen CF, Loyer E Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470. N Engl J Med 338(14):991-992, 1998. PMID: 9527612.
- Wells DC, Loyer EM, Libshitz HI Carcinoma en cuirasse: uncontrolled local recurrence of breast carcinoma after transverse rectus abdominis myocutaneous flap reconstruction. AJR Am J Roentgenol 169(3):914-915, 1997. PMID: 9275930.
- Libshitz HI, DuBrow RA, Loyer EM, Charnsangavej C Radiation change in normal organs: an overview of body imaging. Eur Radiol 6(6):786-795, 1996. PMID: 8972312.
- Termrungruanglert W, Kudelka AP, Piamsomboon S, Edwards CL, Verschraegen CF, Loyer E, Kavanagh JJ Remission of recurrent cervical cancer with Paclitaxel and Carboplatin: a case report and review of literature. Eur J Gynaecol Oncol 17(6):493-496, 1996. PMID: 8971525.
- Loyer EM, Kaur H, David CL, DuBrow R, Eftekhari FM Importance of dynamic assessment of the soft tissues in the sonographic diagnosis of echogenic superficial abscesses. J Ultrasound Med 14(9):669-671, 1995. PMID: 7500432.
- Loyer EM, Shabb NS, Mahon TG, Eftekhari F Fibrous hamartoma of infancy: MR-pathologic correlation. J Comput Assist Tomogr 16(2):311-313, 1992. PMID: 1545033.
- Eggli KD, Loyer EM, Anderson K Neonatal pneumatosis cystoides intestinalis caused by volvulus of the mid intestine. Arch Dis Child 64(8):1189-1190, 1989. PMID: 2782937.
- Loyer EM, Eggli KD Sonographic evaluation of superior mesenteric vascular relationship in malrotation. Pediatr Radiol 19(3):173-175, 1989. PMID: 2654854.
- Loyer EM Congenital left bronchoesophageal fistula. Semin Roentgenol 21(3):169-171, 1986. PMID: 3726562.
Abstracts
- Lenzi R, Claire V, Andrzey K, Vincent M, Wolff R, Abbruzzese JL, Cristofanilli M, Loyer E, Hu W, Kavanaugh J, Rubin E. New escalation scheme for phase I study of drug combination: 9-nitro-20(S)-camptothecin (RFS 2000) with Cisplatin for patients (pts) with advanced malignancies. Proc Am Soc Clin Oncol 21, 2002. e-Pub 2002.
- Kudelka AP, Verschraegen CF, Loyer E, Wallace S, Gershenson DM, Han J, Ho L, Garzone P, Warner M, Bolton MG, Kavanagh JJ. Preliminary report of a phase I study of escalating dose PG-Paclitaxel (CT-2103) and fixed dose Cisplatin in patients with solid tumors. Proc Am Soc Clin Oncol 21, 2002. e-Pub 2002.
- Verschraegen C, Vincent M, Abbruzzese J, Seigler D, Kavanagh J, Loyer E, Kudelka A, Rubin E. Phase I study of 9-nitro-20(S)-camptothecin (RFS 2000) in combination with Cisplatin for patients with advanced malignancies. Proc Am Soc Clin Oncol 19, 2000. e-Pub 2000.
- Kudelka A, Verschraegen C, Vincent M, Levenback C, Wolf J, Bevers M, Loyer E, Brown N, Kavanagh J. Phase II study of intravenous DX-8951f in patients (pts) with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan. Proc Am Soc Clin Oncol 19, 2000. e-Pub 2000.
Book Chapters
- Yedururi S, Salem UI, Avritscher R, Loyer EM. Imaging Response Evaluation. In: Colorectal Liver Metastasis. 1. Springer, Cham, 417-439, 2022.
- Choi H, Loyer E, Kaur H, Silverman PM. Imaging Neoplasms of the Abdomen and Pelvis. In: Cancer Medicine. 7. B. C. Decker, 474-478, 2005.
- Choi H, Loyer E, Charnsangavej C. Radiographic Imaging Following Radiofrequency Ablation of Liver Tumors. In: Radiofrequency Ablation of Cancer: Current Indications, Techniques and Outcomes. Springer-Verlag, 253-268, 2004.
- Tamm EP, Szklaruk J, Loyer E, Faria SC, Charnasangavej C. Radiographic Imaging: CT/MR/PET. In: Pancreatic Cancer. 1. Jones and Bartlett, 165-180, 2004.
- Iyer, RB, Loyer E, Munden RF, Libshitz HI. Effects of Treatment on Normal Tissues: The Thorax. In: Imaging in Oncology. 2. Taylor & Francis, 2004.
- Choi H, Loyer EM, Kaur H, Silverman PM. Imaging Neoplasms of the Abdomen and Pelvis. In: Cancer Medicine. 6. B.C. Decker, 523-527, 2003.
- Kaur H, Loyer E, Lano EA, Charnsangavej C. Pancreatic Cancer: Radiologic Staging. In: Pancreatic Cancer: M.D. Anderson Solid Tumor Oncology Series. Springer-Verlag, 85-95, 2002.
- Libshitz HI, Iyer RB, Loyer EM. Effects of Treatment on Normal Tissues: The Thorax. In: Imaging in Oncology. Isis Medical Media, 1997.
Letters to the Editor
- Aloia TA, Loyer E. Fancier and more expensive doesn't mean better: an argument for CT staging of patients with colorectal liver metastases. Ann Surg Oncol 24: 603-604, 2017.
Selected Presentations & Talks
Local Presentations
- 2019. Hilar cholangiocarcinoma diagnostic and staging. Conference. Eastern & Western Association Liver Tumors 2019. Houston, TX, US.
- 2018. Response evaluation in color rectal hepatic metastases. Conference. Cancer Imaging and Intervention Conference. Houston, TX, US.
- 2017. Neuroendocrine tumors and imaging. Conference. Medical Education Program on Neuroendocrine Tumors. Houston, TX, US.
- 2007. Hepatocellular carcinoma: eastern and western experiences. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2001. Value of triple-phase contrast enhanced multislice helical CT in detection of small pancreatic tumors. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
National Presentations
- 2023. Detection of pancreatic adenocarcinoma in 2022: DECT or high resolution MDCT (Workshop). Invited. Society of Abdominal Radiology 2023 Annual Meeting. Austin, TX, US.
- 2013. A typical imaging presentations of focal nodular hyperplasia with radiologic pathologic correlation. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2013. Pre-operative imaging of hilar cholangiocarcinoma: what the surgeon wants to know. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2012. Strengths and limitations of extravascular and liver specific contrast agents in the evaluation of liver lesions. Conference. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2012. Spectrum of hepatic metastases from neuroendocrine tumors (NETs) and pitfalls of the detection and measurements of the lesions. Conference. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2012. Response imaging evaluation. Invited. Americas Hepato-Pancreato-Biliary Association Consensus Conference. San Francisco, CA, US.
- 2011. Biliary invasion in colorectal metastasis: diagnostic criteria on CT and clinical significance. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2011. New Paradigm for response evaluation of solid tumors in the era of targeted therapy: comparison with traditional size-based response criteria. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2009. New CT findings of response and recurrence independent of change in tumor size in colorectal liver metastasis treated with Bevacizumab. Conference. 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2007. Multimodality imaging of pancreatic metastases. Conference. 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2005. Solitary colorectal liver metastasis: resection determines outcome. Conference. 113th Scientific Session of the Western Surgical Association. Rancho Mirage, CA, US.
- 2004. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Conference. 116th Annual Meeting of the Southern Surgical Association. Palm Beach, FL, US.
- 2004. Gastrointestinal stromal tumor (GIST): role of CT in diagnosis, response evaluation, and surveillance after treatment with Imatinib. Conference. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2003. Identifying resectable pancreatic and periampullary adenocarcinoma with multidetector CT (MDCT). Conference. 89th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2003. Imaging of non-Hodgkin's lymphoma (NHL) of the gastrointestinal track: complimentary roles of computed tomography (CT) and positron emission tomography (PET) with 18F-Fluorodeoxyglucose (18F-FGC). Conference. 89th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2001. Optimizing advanced postprocessing techniques for display of multidetector imaging data for pancreatic and hepatobiliary cancer. Conference. 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2001. Use of thin section multidetector computed tomography images for reconstruction of coronal oblique images for optimal visualization of structures in the hepatoduodenal ligament. Conference. 30th Annual Meeting of the Society of Gastrointestinal Radiologists. Scottsdale, AZ, US.
- 2000. Radiofrequency (RF) ablation of liver tumors: assessment of therapeutic response and complications - update. Conference. 86th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2000. Radiofrequency ablation of liver tumors: assessment of therapeutic response and complications - update. Conference. 53rd Society of Surgical Oncology Annual Meeting. New Orleans, LA, US.
- 1998. Venous invasion in pancreatic carcinoma: CT-pathologic correlation. Conference. 98th Annual Meeting of American Roentgen Ray Society. San Francisco, CA, US.
- 1998. The appearances of renal cell carcinoma metastases in the pancreas using three-phase helical computed tomography. Conference. 98th Annual Meeting of American Roentgen Ray Society. San Francisco, CA, US.
- 1997. Differential enhancement of pancreatic parenchyma in pancreatic ductal adenocarcinoma: new observations in triphasic helical CT. Conference. 83rd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 1997. Biphasic and triphasic helical CT of pancreatic tumors: analysis of patterns of lesion enhancement. Conference. 83rd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 1997. Lesion enhancement characteristics in neuroendocrine tumors of the pancreas: analysis of biphasic or triphasic helical CT. Conference. 83rd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 1997. Potentially resectable pancreatic ductal adenocarcinoma and periampullary carcinoma: analysis of enhancement characteristics on biphasic and triphasic helical CT. Conference. 83rd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 1996. Hepatic pseudolesions: hemodynamic and anatomic concepts. Conference. 82nd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 1995. Uterine and cervical zonal enhancement: evaluation by helical CT and bolus IV contrast enhancement. Conference. 95th Annual Meeting of the American Roentgen Ray Society. Washington, DC, US.
- 1995. Helical CT of the pelvis. Conference. 95th Annual Meeting of the American Roentgen Ray Society. Washington, DC, US.
- 1994. Artifacts in helical CT angiography with multiplanar reformation and maximum intensity projection: experimental evaluation. Conference. 80th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 1994. Diagnosis and staging of pancreatic adenocarcinoma: state-of-the-art CT. Conference. 80th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 1988. Sonographic evaluation of superior mesenteric vascular relationships in malrotation. Conference. 31st Annual Meeting of the Society for Pediatric Radiology. San Diego, CA, US.
International Presentations
- 2022. Revisiting response assessment of colorectal liver metastases: lessons learned and opportunities for improvement. Conference. European Society of Gastrointestinal and Abdominal Radiology. Coimbra, PT.
- 2019. Intrabiliary growth of colorectal metastasis: spectrum of imaging and implications for surgical management. Invited. CRLM International Shanghai Consensus. Shanghai, CN.
- 2018. CT scan, new criteria of response. Invited. New Frontiers in GI Oncology. Montpellier, FR.
- 2018. Response assessment after chemotherapy and ablation. Invited. Rajiv Gandhi Cancer Institute & Research Centre. New Delhi, IN.
- 2017. Response Evaluation in Hepatic tumors. Invited. Sino-US Oncology Symposium. Harbin, CN.
- 2014. What definition for synchronicity? Opinion of the Radiologist. Invited. Synchronous Liver Metastases from Colorectal Cancer - Consensus Conference. Florence, IT.
- 2013. Bevacizumab: clinical experience of the multidisciplinary MD Anderson team, Houston, TX. The radiologist's experience. Invited. AVASTIN Expert Meeting: MD Anderson Houston Experience. Madrid, ES.
- 2012. How to appropriately evaluate the response to treatment? Are RECIST criteria still a valid tool?. Invited. Serono Symposia International Foundation. Rome, IT.
- 2011. Response evaluation after chemotherapy in metastatic colorectal cancer. Invited. Serono Symposia International Foundation. Rome, IT.
- 2003. Comparison of multidetector helical CT and endoscopic ultrasound (EUS) in the detection of pancreatic tumors. Conference. 32nd Annual Meeting of the Society of Gastrointestinal Radiologists. Cancun, MX.
- 2002. Preliminary report of a phase I study of escalating dose PG-Paclitaxel (CT-2103) and fixed dose Cisplatin in patients with solid tumors. Conference. American Society of Clinical Oncology Annual Meeting. Orlando, US.
- 2002. New escalation scheme for phase I study of drug combination: 9-nitro-20(S)-Camptothecin (RFS 2000) with Cisplatin for patients (pts) with advanced malignancies. Conference. American Society of Clinical Oncology Annual Meeting. Orlando, US.
- 2001. Ablation par radiofrequence des tumeurs hepatiques: evaluation radiographique de la reponse therapeutique et des complications. Conference. 49e Journees Francaises de Radiologie. Paris, FR.
- 2000. Phase I study of 9-nitro-20(S)-Camptothecin (RFS 2000) in combination with Cisplatin for patients with advanced malignancies. Conference. American Society of Clinical Oncology Annual Meeting. New Orleans, US.
- 2000. Phase II study of intravenous DX-8951f in patients (pts) with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and Topotecan. Conference. American Society of Clinical Oncology Annual Meeting. New Orleans, US.
- 1998. The appearances of renal cell carcinoma metastases in the pancreas using 3-phase intravenous enhanced helical computed tomography. Conference. Radiology 1998. Birmingham, GB.
- 1998. Venous invasion in pancreatic carcinoma: CT-pathologic correlation. Conference. Radiology 1998. Birmingham, GB.
Patient Reviews
CV information above last modified April 03, 2025